Evidence map›Paper›PMID 31832214›Full record

ArticleNeuro-oncology practice2019

A prospective study of the natural history of incidental meningioma-Hold your horses!

Maziar Behbahani, Geir Olve Skeie, Geir Egil Eide, Annbjørg Hausken, Morten Lund-Johansen, Bente Sandvei Skeie

Registry-linked trialAbstract read
In one paragraph

Article in Neuro-oncology practice, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05254197 (The Risk of Growth in Patients With Non-malignant Brain Tumor), which is not on this map. Cited by 36 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05254197 recruitingnot on this map

The Risk of Growth in Patients With Non-malignant Brain Tumor: SeOuL cOhort of Brain Tumor MONitoring (SOLOMON) Study

Typeobservational_patient_registrySponsorSeoul National University HospitalRan2001 to 2035Enrolled3,000ConditionsBrain Tumor, Primary, Meningioma, Schwannoma, Pituitary Adenoma
3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maziar BehbahaniDepartment of Neurosurgery, Haukeland University Hospital, Bergen, Norway.
Geir Olve SkeieDepartment of Neurology, Haukeland University Hospital, Bergen, Norway.
Geir Egil EideCentre for Clinical Research, Haukeland University Hospital, Bergen, Norway.
Annbjørg HauskenDepartment of Neurosurgery, Haukeland University Hospital, Bergen, Norway.
Morten Lund-JohansenDepartment of Neurosurgery, Haukeland University Hospital, Bergen, Norway.
Bente Sandvei SkeieDepartment of Neurosurgery, Haukeland University Hospital, Bergen, Norway.ORCID 0000-0001-9876-5826

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe number of incidental meningiomas has increased because of the increased availability of neuroimaging. Lack of prospective data on the natural history makes the optimal management unclear. We conducted a 5-year prospective study of incidental meningiomas to identify risk factors for tumor growth.

methodsSixty-four of 70 consecutive patients with incidental meningioma were included. Clinical and radiological status was obtained at 0, 0.5, 1, 1.5, 2, 3, 4, and 5 years. GammaPlan and mixed linear regression modeling were utilized for volumetric analysis with primary endpoint tumor growth.

resultsNone of the patients developed tumor-related symptoms during the study period, although 48 (75%) tumors increased (>15%), 13 (20.3%) remained unchanged, and 3 (4.7%) decreased (>15%) in volume. Mean time to growth was 2.2 years (range, 0.5-5.0 years).The growth pattern was quasi-exponential in 26%, linear in 17%, sigmoidal in 35%, parabolic in 17%, and continuous reduction in 5%. There was significant correlation among growth rate, larger baseline tumor volume (

conclusionThe majority of meningiomas will eventually grow. However, more than 60% display a self-limiting growth pattern. Our study provides level-2 evidence that asymptomatic tumors can be safely managed utilizing serial imaging until persistent radiological and/or symptomatic growth.

Indexed as

asymptomatic meningiomaincidental meningiomanatural historyprospective studyvolumetric tumor growth

Identifiers

PMID31832214
PMCPMC6899048

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.